Physician-related prevalence of dementia, depressive and psychotic symptoms in patients with Parkinson's disease: A national out-patient survey in Germany;Wie beurteilen ärzte die häufigkeit demenzieller, depressiver und psychotischer symptome bei patienten mit der Parkinson-krankheit? Eine befragung von 500 fachärzten im ambulanten versorgungssektor Deutschlands

Aktuelle Neurologie

Volumn 33, Issue 7, 2006, Pages 374-380

  Riedel, O ^a   Dodel, R ^b   Spottke, A ^b   Deuschl, G ^c   Forstl H ^d   Henn, F ^e   Heuser, I ^f   Oertel, W ^g   Reichmann, H ^h   Riederer, P ⁱ   Trenkwalder, C ^j   Wittchen, H U ^a   Backhaus, K ^k   Erichson, B ^k   Plinke, W ^k   Weiber, R ^k  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g PHILIPPS UNIVERSITY MARBURG   (Germany)

^h UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

ⁱ UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^j PARACELSUS ELENA KLINIK   (Germany)

^k NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DEMENTIA; DEPRESSION; DISEASE COURSE; GERMANY; HEALTH SURVEY; HUMAN; OUTPATIENT DEPARTMENT; PARKINSON DISEASE; PHYSICIAN; PREVALENCE; PSYCHOSIS; SEX DIFFERENCE; SYMPTOMATOLOGY;

EID: 33749346059     PISSN: 03024350     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-915473     Document Type: Article

References (43)

1. Klockgether T. Parkinson's disease: clinical aspects. Cell Tissue Res 2004; 318: 115-120
2. Andlin-Sobocki P, Jönsson B, Wittchen H-U, Olesen J. Cost of disorders of the brain in Europe. Eur J Neurol 2005; 12: 1-27
3. Campenhausen S, Bornschein B, Wick R et al. Prevalence and incidence of Parkinson's disease in Europe. Eur Neuropsychopharm 2005; 15: 473-490
4. Aarsland D, Larsen JP, Cummings J, Laake K. Prevalence and clinical correlates of psychotic symptoms in Parkinson's disease - a community-based study. Arch Neurol 1999; 56: 595-601
5. Kuopio A-M, Marttila R, Helenius H et al. The quality of life in Parkinson's disease. Mov Disord 2000; 15: 216-233
6. Spottke A, Reuter M, Machat O et al. Cost of illness and its predictors for Parkinson's disease in Germany. Pharmacoeconomics 2005; 23: 817-836
7. Thommessen B, Aarsland D, Braekhus A et al. The psychosocial burden on spouses of the elderly with stroke, dementia and Parkinson's disease. Int J Geriatr Psych 2002; 17: 78-84
8. Dodel R, Singer M, Köhne-Volland R et al. The economic impact of Parkinson's disease - an estimation based on a 3-month prospective analysis. Pharmacoeconomics 1998; 14: 299-312
9. Hughes T, Ross H, Musa S et al. A 10-year-study of the incidence of and factors predicting dementia in Parkinson's disease. Neurology 2000; 54: 1596-1603
10. Hobson P, Meara J. Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom. Mov Disord 2004; 19: 1043-1049
11. Mayeux R, Denaro J, Hermenegildo N et al. A population-based investigation of Parkinson's disease with and without dementia - relationship to age and gender. Arch Neurol 1992; 49: 492-497
12. Aarsland D, Andersen K, Larsen JP et al. Prevalence and characteristics of dementia in Parkinson's disease - an 8-year prospective study. Arch Neurol 2003; 60: 387-392
13. Aarsland D, Zaccai J, Brayne C. A systematic review of prevalence studies of dementia in Parkinson's disease. Mov Disord 2005; 20: 1255-1263
14. Hughes A, Daniel S, Blankson S. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993; 50: 140-148
15. Hurtig H, Trojanowski J, Galvin J. Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology 2000; 54: 1916-1921
16. McKeith I, Galasko D, Kosaka K. Consensus guidelines for the clinical and pathological diagnosis of Dementia with Lewy Bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996; 47: 1113-1124
17. Braak H, Rüb U, Jansen Steur E et al. Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 2005; 64: 1404-1410
18. Colosimo C, Hughes A, Kilford L, Lees A. Lewy body cortical involvement may not always predict dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry 2003; 74: 852-856
19. Remy P, Doder M, Lees A et al. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 2005; 128: 1314-1322
20. American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders - Text Revision. 4. überarbeitete Auflage. Washington, DC: American Psychiatric Association; 2000
21. Cummings J. Depression and Parkinson's disease: a review. Am J Psychiat 1992; 149: 443-454
22. Cummings J, Masterman D. Depression in patients with Parkinson's disease. Int J Geriatr Psych 1999; 14: 711-718
23. Sano M, Stern Y, Williams J et al. Coexisting dementia and depression in Parkinson's disease. Arch Neurol 1989; 46: 1284-1286
24. Weintraub D. Depression in Parkinson's disease. Prim Psych 2005; 12: 45-49
25. Fahn S. Unified Parkinson's Disease Rating Scale.In: Fahn S, Calne D (eds)Recent Developments in Parkinson's Disease. Florham Park, NJ: MacMillan Healthcare Information; 1987: 153-163
26. Hoehn M, Yahr M. Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427-442
27. Folstein M, Folstein S. MMST - Mini Mental Status Test. Weinheim: Beltz Test GmbH; 1990
28. Folstein M, Folstein S, McHugh P. Mini-mental state: a practical method for grading the mental state of patients by the clinician. J Psychiat Res 1975; 12: 189-198
29. Nishiwaki Y, Breeze E, Smeeth L et al. Validity of the Clock-Drawing-Test as a screening tool for cognitive impairment in the elderly. Am J Epidemiol 2004; 160: 797-807
30. Montgomery S, Asberg M. A new depression scale, designed to be sensitive to change. Brit J Psychiat 1979; 134: 382-389
31. Stata Corp. Stata Statistical Software: Release 9.0. College Station, TX: Stata Corporation; 2005
32. Backhaus K, Erichson B, Plinke W, Weiber R. Multivariate Analyseverfahren. 9. Auflage. Berlin: Springer; 2000
33. Höfler M. Statistik in der Epidemiologie psychischer Störungen. Berlin: Springer; 2004
34. Rudolf M, Müller J. Multivariate Verfahren. Göttingen: Hogrefe; 2004
35. Oertel W, Quinn N. Parkinsonism.In: Brandt T, Diener H, Caplan L (eds)Neurological Disorders: Course and Treatment. San Diego: Academic Press; 1996: 715-772
36. Giladi N, Treves T, Paleacu D et al. Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease. J Neural Transm 2000; 107: 59-71
37. Okun M, Watts R. Depression associated with Parkinson's disease - clinical features and treatment. Neurology 2004; 58: S63-S70
38. Deuschl G. Nichtmotorische Parkinson-Symptome. Akt Neurol 2003; 30: 242-245
39. Holroyd S, Currie L, Wooten G. Depression is associated with impairment of ADL, non motor function in Parkinson disease. Neurology 2005; 64: 2134-2135
40. Witt K, Reiff J, Deuschl G. Die Therapie medikamenteninduzierter psychotischer Symptome beim Morbus Parkinson. Akt Neurol 2004; 31: 361-365
41. Aarsland D, Larsen JP, Lim NG et al. Range of neuropsychiatric disturbances in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1999; 67: 492-496
42. Emre M. Dementia in Parkinson's disease: cause and treatment. Curr Opin Neurol 2004; 17: 399-404
43. Emre M, Aarsland D, Albanese A et al. Rivastigmine for dementia associated with Parkinson's disease. New Engl J Med 2004; 351: 2509-2518